News Hub | News Direct

All Industries


Article thumbnail News Release

The Midwest Emerges as the Robot Capital of America

MarketJar

Robots are poised to revolutionize the way economies function, akin to the transformations brought about by the internet and electricity. But their impact is likely to be uneven across different regions, especially in the short to medium term. According to a recent report by the National Bureau of Economic Research, a staggering 75% of the robots in America are concentrated in merely 10% of the regions, as delineated by the Office of Management and Budget. Conversely, the lower half of these regions have scarcely any robots at all. The study unveils that states including Iowa, Michigan, Kansas, Wisconsin, and Minnesota are at the forefront of using robots in manufacturing. This is a critical advancement, as robots are set to redefine economic structures, mirroring the groundbreaking changes initiated by the introduction of the internet and electricity. The effect of this rise in robotics, however, may differ substantially across various geographical locations. The information came from analyzed census data and surveyed roughly 35,000 manufacturers, shedding light on the localized trends in robotics adoption. A key insight was discovered: rather than supplanting human production workers, robots tend to work alongside them. Furthermore, businesses utilizing robots often sustain a larger human workforce, albeit at typically lower wages. A noteworthy phenomenon is the emergence of robot clusters, where neighboring companies in manufacturing hubs adopt robots at higher rates. This trend is facilitated by the presence of "robot integrators," specialized businesses aiding companies in acquiring and installing robots. Regions with at least one integrator are significantly more likely to become robotic hubs compared to those without such support, according to the report. It isn’t just warehouses and factories that are utilizing robots. Security robots are becoming more and more popular across the US to help fight rising crime rates across the country. By 2030, the global security robot market is expected to reach US$31.08 billion, rising at a CAGR of 12.8%. Among the companies delivering new technologies to the market is Knightscope, Inc. (NASDAQ:KSCP), an advanced security technology company based in the heart of Silicon Valley that builds fully autonomous security robots (ASRs) that deter, detect and report. Enhancing Security Through Robotics Established in 2013, Knightscope, Inc. (NASDAQ:KSCP) stands as a prominent company at the forefront of security robot development with a focus on developing fully autonomous security robots, blue light emergency communication systems, and automated gunshot detection solutions. The company has leveraged four key technologies (autonomy, robotics, artificial intelligence, and EV technology) to create its unique tech, which has been operating in real world conditions for over 2.3 million hours of field operation to date. A significant milestone for Knightscope is its acquisition of CASE Emergency Systems in 2022, enhancing its capabilities and contributing to substantial top-line revenue growth. The company has cultivated an impressive clientele, boasting associations with distinguished entities like the New York Police Department (NYPD), New York City Fire Department (FDNY), San Luis Obispo Council of Governments (SLOCOG), and the Orange County Transportation Authority (OCTA). Since the beginning of the year, Knightscope has inked several major deals across the country, including a $1.25 million contract with Rutgers, The State University of New Jersey for 145 devices, and a pilot contract with the New York Police Department (NYPD) for a K5 robot to patrol a Manhattan subway station. Most recently, Knightscope unveiled a fresh deployment initiative in partnership with a property management group situated in Chicago. The deployment involves a K5 Autonomous Security Robot (ASR), which has taken up patrolling duties within a mixed-use facility housing both retail establishments and professional tenants. This strategic move marks Knightscope 's second deployment in Chicago, targeting an area grappling with escalated levels of crime, trespassing, vehicle break-ins, and catalytic converter thefts. The deployment signifies a resolute step towards enhancing security and curbing criminal activities within the region. The company also achieved a significant milestone by successfully deploying its first two K1 Hemisphere ASR in Hawaii. This deployment marks the pivotal final phase of product development – client testing. The company has entered into a comprehensive evaluation phase with its esteemed client, a globally recognized brand specializing in full-service hotels and resorts. The deployment of a K5 in Ohio has also garnered national attention. For more information on Knightscope, Inc. (NASDAQ:KSCP) and the projects it is working on, visit this link or learn more about the Rise of the Robots at the company's official website. Disclosure: 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Knightscope, Inc. Market Jar Media Inc. has or expects to receive from Knightscope, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) two hundred and sixty-six thousand USD for 89 days (63 business days). 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding Knightscope, Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Knightscope, Inc.’s industry; (b) market opportunity; (c) Knightscope, Inc.’s business plans and strategies; (d) services that Knightscope, Inc. intends to offer; (e) Knightscope, Inc.’s milestone projections and targets; (f) Knightscope, Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Knightscope, Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Knightscope, Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Knightscope, Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Knightscope, Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Knightscope, Inc.’s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) Knightscope, Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Knightscope, Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Knightscope, Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Knightscope, Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Knightscope, Inc.’s business operations (e) Knightscope, Inc. may be unable to implement its growth strategy; and (f) increased competition.Except as required by law, Knightscope, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Knightscope, Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Knightscope, Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Knightscope, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Knightscope, Inc. or such entities and are not necessarily indicative of future performance of Knightscope, Inc. or such entities. 8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

August 18, 2023 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test

Benzinga

By Rachael Green, Benzinga The healthcare technology company Cue Health Inc. (NASDAQ: HLTH) has become the first company to get De Novo authorization from the U.S. Food and Drug Administration (FDA) for an over-the-counter COVID-19 test — as well as being the first FDA De Novo authorization for any over-the-counter molecular test for a respiratory disease. The Cue COVID-19 Molecular Test is designed for both at-home and point-of-care use. Cue Health was also previously the first company to receive an Emergency Use Authorization (EUA) from the FDA for an at-home molecular diagnostic test available without a prescription, which helped the company rake in over $1 billion in revenue over two years from both public (government entities) and private (point-of-care, enterprise, and direct-to-consumer) customers because it is highly accurate and has an easy-to-use design. There are still an average of over 2,000 patients with COVID-19 admitted to hospitals every day in the United States. For both the flu and COVID-19, early diagnosis and treatment are critical to preventing serious illness and even death. In March, the FDA recommended to manufacturers that had received EUAs for their COVID-19 tests to submit new applications and meet the requirements for full clearance in order to keep selling their products. Cue has already achieved that new FDA authorization for its COVID-19 test., and it also has an EUA under FDA review for its Flu A/B + COVID-19 multiplex test, plus additional requests for De Novo classification under review including for its standalone flu test and its respiratory syncytial virus (RSV) test. The company already has an EUA for its molecular test to detect the monkeypox virus. The at-home and point-of-care COVID-19 tests deliver lab-quality results to connected mobile smart devices in about 20 minutes. The test integrates into Cue Care, the company's state-of-the-art test-to-treatment service where patients can connect with a healthcare provider through the Cue Health App to discuss their results, form a treatment plan and have prescribed medications delivered straight to their door. COVID-19 Diagnostics Market Remains As The Disease Becomes Endemic Cue’s De Novo authorization comes as public health officials and epidemiologists have been continuously reporting that COVID-19 has transitioned from pandemic to endemic. Similar to the flu, COVID-19 cases will likely continue to cycle between highs and lows, but in a relatively more predictable manner. Movement into endemic status only means that testing will be even more important and needed over a much longer period of time. Early diagnosis of a respiratory illness can potentially lead to a milder infection and a decreased likelihood of hospitalization. Maintaining vigilance in preventing infection and opting for early detection and treatment at the first sign of symptoms (especially in households with children, senior citizens, family members with disabilities, or other at-risk individuals) can be crucial, especially for COVID-19. Cue Health’s diagnostic platform is able to help both patients and care providers stay ahead of COVID-19 over the long term, as the disease enters its endemic stage. By providing fast and accurate results, the platform could help minimize the spread of the disease and the risk of hospitalizations. Cue’s Molecular Diagnostic Platform — A Game Changer For Testing Cue’s test is a NAAT (Nucleic Acid Amplification Test) that amplifies and detects the virus’s RNA. Because it can amplify the genetic material, Cue’s test is much more sensitive than an antigen test. In clinical studies, the Cue COVID-19 Molecular Test matched three FDA-authorized, lab-based PCR tests with 98% accuracy. The company’s innovative technology turned the complex test into a user-friendly kit that requires no advanced training. Cue’s molecular test is proven to deliver accurate results even in the early days after exposure whereas antigen results are not nearly as reliable. This is important as, according to the CDC, treatment must be started within days after you first develop symptoms to be effective. Cue's molecular test, which delivers results in 20 minutes, is also much faster than a PCR test, which can take anywhere from 12 hours to five days. The test can be used on adults or children with or without signs or symptoms of COVID-19 and it is self-contained, meaning it doesn’t involve mixing fluids or running an involved testing procedure. Users simply insert the cartridge into their Cue Reader, collect a nasal sample with a Cue Sample Wand, and insert the Wand into the cartridge. About 20 minutes later, results are sent to the Cue Health App on the user’s phone. With its head start in the transition from EUA to permanent market authorization for its at-home COVID-19 molecular test and a slate of additional at-home tests compatible with the same Cue Reader device, analysts have expressed optimism about the healthcare tech company’s future earnings potential. This document may depict certain future planned care offerings which are subject to completion of development and/or may require regulatory authorization, clearance, or approval before they can be commercialized. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 18, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Hart + Harvest Press Announces New Edition of James F. Haggerty’s Chief Crisis Officer, featuring an Insightful New Preface on the COVID and Ukraine Crises

PRCG | Haggerty LLC

“Not having a crisis plan is like sending your team onto the field, and only then making up the plays. You may win the game… but I wouldn’t bet on it.” Hart + Harvest Press is thrilled to release the latest edition of Chief Crisis Officer: Structure and Leadership for Effective Communications Response, by noted attorney, author and communications consultant James F. Haggerty. The new edition is now available for purchase on platforms such as Amazon, Barnes & Noble, independent booksellers, and at hartandharvest.com. The Hart + Harvest edition of Chief Crisis Officer features a new preface that provocatively looks at the communication impacts of two of the most dominant crisis events of the past several years: the COVID-19 pandemic, and Russia’s 2022 invasion of Ukraine. On the COVID crisis, Haggerty writes that the government’s disastrous public response “serves as a prime example of why basic principles of crisis communications are so critical, including: having structure and leadership in place for response before a crisis occurs; ensuring an actionable plan that everyone understands and buys into; understanding the importance of rapid response protocols in an age of social media and other instant communications; and creating messages that are compelling and clear… messages that resonate with your audience.” On the subject of messaging, Haggerty contrasts the COVID failures with the success of President Volodymyr Zelensky in the wake of Russia’s 2022 invasion of Ukraine. “As in the public speeches of Churchill, Roosevelt and Ronald Reagan,” Haggerty writes, “Zelensky chose his words and images incredibly carefully, rallying the Western world to a cause thought hopeless in the early days of the conflict.” Haggerty adds: “There was no committee noodling his words on Google Docs, adding various equivocations and lawyerly qualifications. No banal clichés. None of the muddied verbiage of the type that ensures that the bulk of your audience doesn't hear your message at all.” Structure and Leadership In Chief Crisis Officer, Haggerty emphasizes the necessity for all organizations, regardless of size, to (1) have the structure in place for effective communications response, and (2) appoint a leader who can execute in the heat of the modern crisis—the “Chief Crisis Officer.” “Crisis communications planning is not merely for the largest of companies facing the biggest of issues in the most major of media outlets,” Haggerty writes. “Effective crisis communications is for everyone involved with issues or events that could negatively impact their organization.” Throughout the book, readers will gain insights into crisis management, including the anatomy of a crisis, the selection of a Chief Crisis Officer, the creation of a crisis communications plan, rapid response strategies, crafting the right messages, and more. Since its original release, Chief Crisis Officer has become mandatory reading for CEOs, business executives, lawyers, public affairs and public relations executives, and high-profile individuals who seek guidance in crisis management. Prior editions of Chief Crisis Officer have been positively featured in publications that include the Harvard Business Review, Fortune and Entrepreneur magazines. About James F. Haggerty Called a “powerhouse of PR and communications” by Chambers & Partners’ international directory, James F. Haggerty is a well-known author, attorney and communications consultant. Haggerty is CEO of PRCG | Haggerty LLC, an internationally renowned public relations firm based in New York City, and its sports brand, PRCG | Sports. He is also president of the Crisis Protection Network (CPN), an association of senior communications executives in 16 cities worldwide. Haggerty is also the author of In the Court of Public Opinion: Winning Strategies for Litigation Communications, Third Edition (Hart + Harvest Press, 2022), which has been called “the perfect handbook for this age of show trials…” by Financial Times. The first business book to examine the interplay of media, public relations, and public perception during litigation, In the Court of Public Opinion was named one of the Top 10 PR Books of the Year by The Holmes Report. A 20 th anniversary edition will be published in 2023. About Hart + Harvest Press Hart + Harvest Press is an independent publishing company specializing in compelling nonfiction written by experts in business, communications, public policy, and related fields. Established and backed by PRCG, Hart + Harvest is driven by a genuine passion for storytelling—narratives that inspire, thoughts that provoke, and critical thinking that test conventional wisdom. Above all, Hart + Harvest firmly believes in the power of language to entertain, enlighten, and persuade. Contact Details Hart + Harvest Press Sandra Prendergast +1 212-683-8100 sprendergast@hartandharvest.com Company Website https://hartandharvest.com/

August 18, 2023 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Could Pomerdoge (POMD) New P2E Crypto Meme Overtake Shiba Inu (SHIB) And Dogecoin (DOGE) In 2024?

Pomerdoge

Pomerdoge is an upcoming P2E crypto sensation that may leave behind others in 2024. In fact, investors of Shiba Inu (SHIB) and Dogecoin (DOGE) may pick the new project due to its potential. Let us see the secrets behind its potential rise, and why it's becoming the talk of the crypto town. Summary: Shiba Inu (SHIB) may trade at $0.000009879 on average - some traders predict. Dogecoin (DOGE) to reach $0.07 by year's end. Pomerdoge sales begin at $0.007. Click Here To Find Out More About The Pomerdoge (POMD) Presale Shiba Inu (SHIB) Talks On The Shibarium Launch; The Token Trades At $0.00001002 The Shiba Inu (SHIB) network team has recently been advertising Shibarium's launch. The community members expect the buzz to raise the Shiba Inu (SHIB) token price. Furthermore, users also anticipate Shibarium's design to solve network congestion. Additionally, the Shiba Inu (SHIB) platform often faces scalability issues. But, Shibarium may tackle the situation. Some believe that the new launch may leverage the Shiba Inu (SHIB) ecosystem to evolve the Ethereum network. Besides Shibarium, the completion of many other pending projects also took place. Some traders suggest that Shiba Inu (SHIB) token may trade at an average price of $0.000009879. Currently, it is selling at $0.00001002, a 9.30% rise in a day. Dogecoin (DOGE) Appears On Hulu's Series; Token Trades At $0.07567 It's not new that popular TV shows often mention cryptocurrencies. Something similar happened with Dogecoin (DOGE). Recently, the token appeared in a new Futurama series. It's an animated series that people can stream on Hulu. However, people can also see Dogecoin's (DOGE) creator's reaction to the series on social media. He says how his silly creation, Dogecoin (DOGE), is now making its way to the Futurama episode. In fact, he has repeatedly mentioned that Dogecoin (DOGE) creation was just a fun task for him. But, presently, the token is quite popular. However, Dogecoin (DOGE) needs many improvements when it comes to use cases. The token has a live price of $0.07567, after a 2.85% dip in the past 24 hours. It is 91% down from its all-time high records, and may trade at an average price of $0.07 by year's end. Pomerdoge May Lead The Online Gaming And Trading World Altogether In just one year, from 2022's 1st quarter, the blockchain gaming sector saw an incredible 2,000% growth. Undoubtedly, it's the best time for P2E games to emerge. One such platform that'll be launching soon is Pomerdoge. The gaming platform wishes for many use cases, and a reliable gamer network. To make it happen, the platform will offer many services to gamers. For example, players can trade their in-game stuff to earn money. Additionally, it plans to lock the liquidity forever, keeping players' investments safe. Thus, the platform players will get more value compared to other altcoins. There are other benefits, too, such as: Trading access to Pomergplace, an in-built trading marketplace. Access to 7,777 NFTs for presale members only at 0.2 ETH per NFT. Chance to join fun Arena competitions. Tools to build desired avatars. Stay up to date on the POMD project to catch the early presale! Find out more about the Pomerdoge (POMD) Presale Today Website: https://pomerdoge.com/ Telegram Community: https://t.me/pomerdoge This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Cryptocurrency is a volatile market; do your independent research and only invest what you can afford to lose. New token launches and small market capitalization coins are inherently more risky than large cap cryptocurrencies. These tokens are subject to larger liquidity and market risks. Contact Details Rose Williams press@pomerdoge.com Company Website https://pomerdoge.com

August 18, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Nearly 2 In 5 American Workers Are Now Freelance – Here’s How They’re Keeping Dental Costs Down Even Without Employer-Sponsored Dental Insurance

DentalPlans.com

By Rachael Green, Benzinga In the first year of the pandemic, approximately 2 million Americans switched from traditional employment to freelance or contract jobs bringing the total percentage of the U.S. workforce that freelances from 28% in 2019 to 36% in 2020. By 2022, that percentage had grown to 39% — or 60 million Americans — suggesting that the trend is here to stay even as other parts of the economy return to their pre-pandemic norm. While freelance or contract work brings flexibility and more control over work/life balance to American workers, it also often places the costly burden of paying for insurance entirely out of pocket. The average monthly premium contribution employees pay for employer-sponsored plans is $110 for single coverage. Meanwhile, self-employed workers pay an average of $560 for the same coverage. That’s not even counting dental insurance, which can add another $46 to the monthly insurance bill for a self-employed person – more if they need to provide coverage for a family. Dental Savings Plans Are An Easy, Low-Cost Alternative To Dental Insurance According to survey research by the USDA, self-employed workers were twice as likely as employees to be completely uninsured, with approximately one in five self-employed workers going without health insurance. Approximately 84% of people without health insurance also don’t have dental coverage. Another 50% of self-employed workers were covered by a family member’s employer-sponsored plan or by taking on a second job from an employer who offered health insurance to avoid paying the high premiums for an individual plan. Though a potentially steep financial burden has pushed many freelance and contract workers to the risky decision to skip or scale back insurance coverage, it’s important to know that insurance and no insurance are not your only options. One way to keep those costs under control is with a dental savings plan. Regardless of your insurance status, signing up for a dental savings plan on DentalPlans.com can save you an average of 50%* on your dental care. After signing up, simply show your membership card to any participating dentist, and you’ll be charged the discounted rates included in your plan. Dental savings plans provide savings on virtually all dental procedures, have no annual limits, no restrictions on who can sign up or when and activate in as little as one to three days. Visit DentalPlans.com to find tools that help you choose the best plan for your unique needs. Filter plans by dentist, location and procedures and get a personalized dental plan recommendation right away. DentalPlans.com, founded in 1999, is a leading online marketplace for dental savings plans in the U.S., helping more than a million people to affordably access quality healthcare services. Our mission is to empower consumers with the tools, information, and services that they need to live happier, healthier lives. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. *Discount Health Program consumer & provider surveys indicate average savings of 50%. Savings may vary by provider, location, and plan. Contact Details Matthew Wong matthew.wong@wpromote.com Company Website https://www.dentalplans.com/

August 18, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Ventripoint Unveils New Integrated Product with ASCEND Cardiovascular

Ventripoint Diagnostics Ltd.

Toronto, Ontario – TheNewswire – August 18, 2023 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ( OTC:VPTDF) is thrilled to announce that Ventripoint and ASCEND Cardiovascular, LLC  have developed a new integrated product.  Today’s announcement marks a significant milestone in Ventripoint’s commitment to the collaboration between the two companies. ASCEND fits perfectly into Ventripoint’s roadmap for innovation and is a key step in the company’s mission to improve patient’s lives and become the standard of care.   ASCEND is seamlessly integrated with leading EHRs, and imaging systems.  Their existing technology has been installed at 1000+ top ranked healthcare facilities and 600+ health systems with approximately 50,000 users across the United States.   Ventripoint has successfully and seamlessly integrated its specialized AI-powered 3D Echo software application with ASCEND’s diagnostic viewer, InView, and reporting application, Cardiovascular Structured Reporting.  This cardiovascular workflow product provides an end-to-end solution that rivals other products on the market.  It is streamlined, smart, and effective for cardiology reading, reporting, and diagnostics, thereby improving diagnosis and monitoring of fetal, pediatric, and adult congenital heart disease.   “We are excited to embark on this collaborative journey with ASCEND Cardiovascular,” stated Dr. Alvira Macanovic, President & CEO of Ventripoint Diagnostics. “We see this collaboration evolving progressively in its possibilities.  We believe that by integrating Ventripoint’s technology in diagnostic medical imaging with ASCEND’s expertise in cardiology IT this will be a successful integrated product. The product will offer a seamless and comprehensive approach to diagnosing and treating cardiovascular conditions.” After months of development, Ventripoint stands ready to successfully unveil this integrated product with its newest partner at the 8 th World Congress of Pediatric Cardiology and Cardiac Surgery in Washington, DC later this month. "This is an important milestone and validation of ASCEND’s commitment to providers caring for children with heart disease. We are excited to enable the routine, efficient use of Ventripoint's advanced 3D image analysis in pediatric cardiology," stated Dr. Jeff Soble, CEO of ASCEND.   As the collaboration between Ventripoint and ASCEND continues to evolve, both companies remain committed to driving innovation and excellence in cardiovascular health technology. This integrated product marks an exciting milestone in the advancement of cardiac care and solving today’s and anticipating tomorrow’s challenges.   About Ventripoint Diagnostics Ltd. Ventripoint has become known for the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary AI technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. Ventripoint's VMS products are powered by its proprietary KBR technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe and Canada.  Learn more:   www.ventripoint.com. About ASCEND Cardiovascular ASCEND Cardiovascular is a leader in innovating cardiovascular solutions that empower the provider community to improve cardiovascular care. Designed with openness in mind, their solutions integrate with EHRs, medical devices, and other systems to deliver seamless workflows that span procedure types and modalities. A complete cardiovascular solution, ASCEND provides structured reporting, image visualization, collaboration, and analytics that improve efficiency, outcomes, and ROI. With decades of experience and a practicing cardiologist at our helm, the ASCEND team brings unparalleled “know how” in cardiology workflow, collaboration, and IT offering limitless opportunities to improve clinical, operational, and quality performance. Learn more:  www.ascendcv.com. For further information, please contact: Jonathan Robinson CFA JRobinson@oakhillfinancial.ca (416) 669-1001 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. Forward Looking Statements This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends'' and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Factors which could materially affect such forward-looking information are described in the risk factors in the Company's most recent annual management's discussion and analysis that is available on the Company's profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

August 18, 2023 08:01 AM Eastern Daylight Time

Article thumbnail News Release

BingX launches World's first 0 slippage BTC Derivatives Trading

BingX

SINGAPORE - Media OutReach - 18 August 2023 - BingX, a copy trading cryptocurrency exchange, is thrilled to announce enhancements to its derivatives trading systems, aimed at meeting the needs of its ever-growing trader community. This strategic upgrade reaffirms BingX's commitment to delivering good trading experiences and raising its reputation as a cutting-edge platform in the cryptocurrency industry. Key Improvements include: 1. Pin-Point Accuracy for Seamless Trading: No Slippage: BingX now guarantees precision in trade execution, ensuring traders experience no slippage while opening or closing orders. This enhancement provides traders with the exact entry and exit points they desire, minimizing discrepancies between intended and executed prices. Precise Stop Loss and Take Profit: With no slippage mechanism in place, BingX also introduced an advanced mechanism for setting stop loss and take profit levels, allowing traders to exercise complete control over their trades and risk management strategies. 2. Enhanced Leveling Mechanism and Improved Fund Management: Effective Large Funds Management: BingX's upgraded derivatives trading system offers enhanced fund management capabilities, minimizing the risk of abnormal liquidation during volatile market conditions. This enhancement ensures that large funds are efficiently managed, safeguarding traders' investments. 3. Seamless Compatibility with Financial Tools: TradingView Signals for Automated Trading: BingX introduces seamless integration with TradingView signals, empowering traders with automated trading strategies based on real-time data analysis. This integration provides an added layer of convenience and precision in executing trades. MT5 Compatibility: BingX now supports MetaTrader 5 (MT5), a widely renowned trading platform. This compatibility expands traders' choices and access to advanced trading tools. These improvements come to us live on BingX trading platform as of August 2023. As the crypto market evolves, BingX remains dedicated to providing a secure, seamless, and feature-rich platform that caters to the diverse needs of traders. About BingX Founded in 2018, BingX is a leading crypto exchange that offers spot, derivatives, copy, and grid trading services to over 100 countries and regions worldwide with over 5 million users. BingX continues to connect users with expert traders and the platform in a safe and innovative way. Find out more about BingX Signal Trading. Download BingX iOS and Android App for better mobile trading experience. Contact Details BingX Elvisco elvisco@bingx.com Company Website https://bingx.com/en-us/

August 18, 2023 12:15 AM Eastern Daylight Time

Article thumbnail News Release

Renaissance Search and Consulting: Paving the Path for Gen Z-Driven Diversity Across Global Industries

500NewsWire

Los Angeles, California, August 17, 2023 ( 500NewsWire ) -- The demand for diversity and inclusion across industries is gaining momentum in the rapidly shifting global marketplace. However, many sectors need to reflect this evolution. Answering this call is Renaissance Search and Consulting (RSC), a minority-owned search firm from Los Angeles with an ambitious strategy to revolutionize recruitment across diverse sectors. The clamor for greater inclusivity resonates even louder as Gen Z and Millennial demographics continue to make their presence felt in the workforce. With their unique perspectives, there's a pressing need to incorporate and understand their voices. Recognizing this imperative, RSC has dedicated itself to creating a more inclusive, diverse, and adaptable workforce spanning many sectors. Herb Courtney II, a leading figure at RSC, aptly expresses his stance: "Diversity is a crucial force in creating innovative, adaptable, and resilient organizations." His vision encapsulates the transformative potential of diversity. For him and his team, it’s not just about filling vacancies but using diversity as an impactful tool to reshape the entire industry spectrum. As RSC gears up for a surge in new workforce entrants, its commitment to championing diversity and addressing entrenched barriers stands out. Their all-encompassing recruitment approach is rooted in a diverse talent pool, ensuring richness in backgrounds and experiences. Setting them apart, the company takes pride in its hands-on engagement in the recruitment journey. They shun the repetitive cycle of candidate recycling and, instead, delve deep into their expansive network that spans myriad industries. RSC’s expertise isn't confined to recruitment alone. They offer invaluable workplace consulting, partnering with firms to cultivate environments that prize talent growth and retention. Moreover, their Career Institute, a virtual platform, presents coaching sessions for professionals, particularly those from emerging demographics. This initiative empowers these professionals with critical skills, preparing them to confidently stride through their respective industries and enhance their career trajectories. RSC remains unwavering in its mission despite challenges like inherent biases and systemic barriers. With the rising prominence of Gen Z in the global workforce, the urgency for diverse and inclusive teams grows. Renaissance Search and Consulting is at the forefront of this shift, poised to influence multiple industries. Visit the Renaissance Search and Consulting website for insights into their groundbreaking strategies and future projections. As we anticipate a shift towards greater diversity and inclusion, it's intriguing to see how these pioneering efforts may redefine the landscape of various sectors in the coming years. Contact Details Nadya Rousseau +1 310-853-3798

August 17, 2023 10:57 PM Eastern Daylight Time

Image
Article thumbnail News Release

Kentucky's Hip Hop Artist Vito Tisdale Aka Big V Launches New Movie Following 50th Anniversary Of HipHop Culture.

KISS PR Brand Story

New York, New York, USA, WEAM Media, Solomon Productions, Spice Star Group, present the movie “The Dirty South Movie.” Visit: TheDirtySouthMovie.com. In honor of the 50th Birthday of Hip Hop, fans and Hip Hop professionals globally will see the first official movie about Southern Hip Hop and Rap (Dirty South Rap/Hip Hop). The Dirty South Movie has appearances by various artists, rising. stars, music producers, executives, athletes, and actors who give their exciting perspectives on the multiple styles of music. from the region. Several never told stories are being disclosed, and unique tactics are utilized to break into the Hip Hop industry. Some members of the cast also re-enact music clubs, street action, concerts, and other real-life scenarios. The Production team is Mr. J. Curry and Mr. P. Solomon. The film stars Big V (formerly of Nappy Roots), Urban Mystic, Charlie P, Ron Spalding, Kyng Of Da Beatz, Dame Debiase, Twang and Round, DJ Jiggy, Sahara Eyes, and more. These styles include. Southern Rap, Country Hip Hop, Bounce, Chopped and Screwed, Crunk, Miami Bass, Phonk, Plugg, Trap, Memphis, and more. Additional song production from Kyng Of Beatz, and clothing design by Abstract Lyfe and Sahara Eyes. For screenings, music soundtrack, merchandising or to discuss other entertainment contact: kingpatsolomon.@gmail.com or ( 347 ) 915-7142 kingjamescurry@gmail.com ExQuisite PR Firm LLC nicole@exquisitepr4u.com or (708 )491-8049 You can receive an EPK or press pass by requesting via email, you must provide valid credentials.   Release ID: 704110

August 17, 2023 10:30 PM Eastern Daylight Time

Image
1 ... 813814815816817 ... 3516